Ocular Therapeutix (OCUL) Operating Margin Growth (5y) (2019 - 2026)
Ocular Therapeutix (OCUL) Operating Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ocular Therapeutix | 1.91 Bn | 1.91 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58,995.00 |
| Dec 31, 2025 | -33,132.00 |
| Sep 30, 2025 | -23,399.00 |
| Jun 30, 2025 | 63,726.00 |
| Mar 31, 2025 | 3,933.00 |
| Dec 31, 2024 | 65,255.00 |
| Sep 30, 2024 | 249,359.00 |
| Jun 30, 2024 | 305,779.00 |
| Mar 31, 2024 | 378,152.00 |
| Dec 31, 2023 | 329,370.00 |
| Sep 30, 2023 | 284,770.00 |
| Jun 30, 2023 | 195,776.00 |
| Mar 31, 2023 | 378,875.00 |
| Dec 31, 2022 | 247,353.00 |
| Sep 30, 2022 | 272,549.00 |
| Jun 30, 2022 | 402,462.00 |
| Mar 31, 2022 | 316,414.00 |
| Dec 31, 2021 | 229,406.00 |
| Sep 30, 2021 | 177,599.00 |
| Jun 30, 2021 | 234,595.00 |